Acelyrin Inc. (SLRN): Total Asset Value of Company

Acelyrin, Inc. (SLRN) business development relies on the efficacy of isokibep in treating arthritis and psoriasis. This chart reflects an asset value of 566.98, which is critical amid program reductions following the failure of its primary anti-inflammatory project and a fierce struggle for liquidity. Meanwhile, the company is developing therapies for dermatological diseases that guarantee long-term revenue through lifelong medication adherence.

Acelyrin, Inc. (SLRN) Company Total Assets: for the period 02/21/2024 - 05/31/2025

This indicator, calculated by reversing the return on assets ratio, reflects the total value of resources and liabilities of Acelyrin, Inc. (SLRN), allowing investors to track the capitalization dynamics of the asset base. Growth in total assets confirms the expansion of the company's financial potential to develop its pipeline of drugs against immune pathologies, although an excessive increase in this metric may signal inefficient capital management.

Competitors of Acelyrin, Inc. (SLRN)

HLN (haleon.com) - Total Business Assets|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Cumulative Company Assets|Aggregate Asset Value SPRY (ARS Pharmaceuticals Inc)|TBPH: Aggregate Company Assets|AQST - Company Assets|Cumulative Company Assets scPharma SCPH|TECX - Aggregate Business Assets|Company Total Assets Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Aggregate Asset Value|Company Total Assets EPRX (Eupraxia Pharmaceuticals, Inc.)|Company Assets BHST|eXoZymes Inc (EXOZ) - Aggregate Company Assets|Aggregate Asset Value oramed.com (ORMP)|Company Total Assets ENTX (Entera Bio)|Company Total Assets MindWalk Holdings, Inc. HYFT|ABVC: Company Total Assets|CPIX - Cumulative Company Assets|Company Total Assets QNTM|FGEN (fibrogen.com) - Company Assets|Aggregate Company Assets Telomir Pharmaceuticals, Inc.|Aggregate Company Assets Rani Therapeutics Inc (RANI)|Synergy CHC Corp - Cumulative Company Assets|Company Assets RLYB (rallybio.com)|Aggregate Company Assets Lexaria Bioscience Corp.|Aggregate Asset Value pulmatrix.com PULM|Company Total Assets PTHL (Pheton)|APM: Company Total Asset Base|Aggregate Company Assets Lyra Therapeutics, Inc|Total Business Assets Impact BioMedical, Inc.|TNFA - Cumulative Company Assets|Aggregate Asset Value cbdMD Corp|PRFX (PainReform) - Company Total Assets|Company Total Asset Base CYTO (altamiratherapeutics.com)|LIPO - Aggregate Company Assets|Total Business Assets OptiNose Corp OPTN|PIRS: Company Total Assets|procapsgroup.com (PROC) - Cumulative Company Assets|Petros Pharmaceuticals, Inc. - Cumulative Company Assets|QLI (Qilian International Holding Group) - Company Total Asset Base|TFFP: Aggregate Company Assets